NCT06455436 Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments
| NCT ID | NCT06455436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitat Internacional de Catalunya |
| Condition | Dental Implant |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-05-08 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-05-08 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The loss of a tooth leads to a series of biological changes in the tissues, resulting in bone resorption and gingival collapse. To avoid these problems, it has been proposed to place immediate post-extraction implants, allowing a reduction in treatment time and the number of surgeries, as well as better maintenance of the tissues. This technique can be performed with standard abutments after implant placement or, more recently, the use of temporary abutments has been proposed.
Eligibility Criteria
Inclusion Criteria: * Adult patient ( 25 years old). * Need for extraction of an irrational tooth to be treated in the molar/premolar position of the upper/lower arch. * Presence of 2mm of keratinized gingiva. * Bone dehiscence in the alveolar walls of 2 mm. 2 mm. * Adequate amount of bone in the interradicular septum to stabilize the implant (minimum height 10 mm, minimum width 4 mm at the base of the septum). * Plaque index (FMSPI, full mouth score plaque index) \< 10%. * Non-smokers or smokers of less than 10 cigarettes per day. * Absence of systemic diseases that contraindicate implant surgery. Exclusion Criteria: * Presence of alveoli with dehiscence \>2mm. * Presence of adjacent implants. * \< 2mm of keratinized gingiva. * Presence of active infection (fistula, suppuration) at the extraction site. * Presence of apical granuloma \>2mm in diameter in the root(s) of the tooth or teeth to be extracted. * Residual bone apical to the extraction insufficient to anchor the implant. * Pregnant or lactating women. * Severe cognitive or psychiatric disorders. * Compromised general health status ( ASA IV). * Use of drugs that alter bone metabolism and healing. * Absence of manual primary stability of the implant * Bone dehiscence or fenestration after implant placement (manual rotation). * Gap 2mm between the implant and the vestibular bone wall.
Contact & Investigator
Matteo Albertini, PhD
PRINCIPAL INVESTIGATOR
Universidad Internacional de Catalunya
Frequently Asked Questions
Who can join the NCT06455436 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, studying Dental Implant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06455436 currently recruiting?
Yes, NCT06455436 is actively recruiting participants. Contact the research team at jvilarrasa@uic.es for enrollment information.
Where is the NCT06455436 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT06455436 clinical trial?
NCT06455436 is sponsored by Universitat Internacional de Catalunya. The principal investigator is Matteo Albertini, PhD at Universidad Internacional de Catalunya. The trial plans to enroll 32 participants.